We determined the amount, subclass-distribution, and inhibitory potential of anti-ADAMTS13 IgG antibodies in anti-ADAMTS13 IgG-positive samples of a large and homogenous group of ADAMTS13-deficient acquired TTP patients. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.